Glanbia PLC is a ingredient and branded performance nutrition manufacturer company... Show more
The Moving Average Convergence Divergence (MACD) for GLAPY turned positive on January 29, 2026. Looking at past instances where GLAPY's MACD turned positive, the stock continued to rise in of 23 cases over the following month. The odds of a continued upward trend are .
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. GLAPY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock slightly better than average.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.342) is normal, around the industry mean (37.392). P/E Ratio (42.128) is within average values for comparable stocks, (84.548). GLAPY's Projected Growth (PEG Ratio) (8.073) is slightly higher than the industry average of (2.700). Dividend Yield (0.023) settles around the average of (0.036) among similar stocks. P/S Ratio (1.303) is also within normal values, averaging (37.896).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
Industry FoodMajorDiversified
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| REMCX | 20.81 | 0.27 | +1.31% |
| Russell Inv Emerging Markets C | |||
| AMALX | 10.83 | 0.01 | +0.09% |
| American Century Small Cap Dividend G | |||
| FLCKX | 45.88 | N/A | N/A |
| Fidelity Leveraged Company Stock K | |||
| VEXAX | 163.12 | -0.32 | -0.20% |
| Vanguard Extended Market Index Admiral | |||
| HSRUX | 28.06 | -0.11 | -0.39% |
| Carillon Eagle Small Cap Growth R6 | |||
A.I.dvisor tells us that GLAPY and GLUC have been poorly correlated (+6% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GLAPY and GLUC's prices will move in lockstep.
| Ticker / NAME | Correlation To GLAPY | 1D Price Change % | ||
|---|---|---|---|---|
| GLAPY | 100% | N/A | ||
| GLUC - GLAPY | 6% Poorly correlated | -5.19% | ||
| GPDNF - GLAPY | 4% Poorly correlated | +4.47% | ||
| GRBMF - GLAPY | 2% Poorly correlated | -8.99% | ||
| HLNFF - GLAPY | 2% Poorly correlated | -0.61% | ||
| FPAFY - GLAPY | 2% Poorly correlated | -1.97% | ||
More | ||||
| Ticker / NAME | Correlation To GLAPY | 1D Price Change % |
|---|---|---|
| GLAPY | 100% | N/A |
| Food: Major Diversified industry (196 stocks) | 1% Poorly correlated | -0.64% |